NAYA Biosciences
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $1,433 | $1,836 | $1,576 | $1,381 |
Gross Profit | 444 | 974 | 726 | 495 |
EBITDA | -1,097 | -1,645 | -1,186 | -1,648 |
EBIT | -1,327 | -1,875 | -1,413 | -1,789 |
Net Income | -1,630 | -2,245 | -1,596 | -1,994 |
Net Change In Cash | 1,433 | 1,836 | 1,576 | 1,381 |
Free Cash Flow | -640 | -1,510 | -310 | -789 |
Cash | 471 | 942 | 475 | 232 |
Basic Shares | 3,885 | 3,609 | 3,801 | 2,492 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $3,020 | $822 | $4,160 | $1,037 |
Gross Profit | 1,086 | -28 | 4,015 | 948 |
EBITDA | -6,880 | -10,752 | -5,218 | -5,476 |
EBIT | -7,080 | -10,830 | -5,384 | -5,510 |
Net Income | -8,034 | -10,892 | -6,654 | -8,347 |
Net Change In Cash | 3,020 | 822 | 4,160 | 1,037 |
Free Cash Flow | -5,199 | -6,616 | -6,484 | -4,864 |
Cash | 232 | 90 | 5,684 | 10,097 |
Basic Shares | 3,131 | 2,424 | 2,126 | 1,097 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.62 |
2024-03-31 | -$0.41 |
2023-09-30 | -$0.70 |
2023-06-30 | -$3.05 |
